Events9th International Electronic Conference on Medicinal Chemistry
Published
with-doi10.3390/ECMC2023-15655 (registering DOI)
This submission belongs to the session S4. New Small molecules as drug candidates of the event 9th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2023
Academic Editor
author-avatarMaria Emília Sousa
Citation
Oleksandr Nuzhnyi, Zenovii Tkachuk, Roman Nikolaiev, Interactions of synthetic oligonucleotides with signaling proteins and their receptors, in Proceedings of 9th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2023, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2023-15655
Share
Email
Facebook
Twitter
LinkedIn

Interactions of synthetic oligonucleotides with signaling proteins and their receptors

1. The Institute of Molecular Biology and Genetics of the National Academy of Sciences of Ukraine (IMBG of the NASU), Ukraine, Ukraine
Abstract

The study aimed to synthesize, purify, and investigate the interaction of oligonucleotides (OLNs) with recombinant signaling proteins and their receptors, assessing the binding strength using fluorescence analysis and the Stern-Volmer equation. OLN-1 to OLN-8 were synthesized and purified, and their purity confirmed by HPLC. Fluorometric titration revealed static binding of OLNs to proteins, forming non-fluorescent complexes, except for OLN-3 with insulin (INS) and OLN-2 with interferon α2-β (INF α2-β), showing mixed binding. This indicates that these proteins interacted with OLNs at very low concentrations. OLN-1, OLN-6, OLN-7, and OLN-8 exhibited high binding activity to all proteins. Moreover, positive cooperative binding (2A+B=A2B) was observed in some cases, where one OLN molecule facilitated the attachment of the next due to conformational changes. OLN-3 and OLN-4 displayed significant positive cooperative binding with INF α2-β. In conclusion, the study demonstrated a strong interaction between OLNs and recombinant signaling proteins and receptors, potentially influencing their conformation and biological activity. These findings have implications for the therapeutic use of OLNs in the context of signaling proteins and receptors.

Keywords
Oligonucleotides
Signaling proteins
Receptors
Synthesis
Manuscript
Oral Presentation
DNA/BSA binding affinity of pyocyanin produced by Pseudomonas aeruginosa
The X-ray structure of the primary adduct formed upon reaction between dirhodium tetraacetate and B-DNA double helical dodecamer